Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Open in API
Filings indexed 1,608 across all filing types
Latest filing 2020-11-05 Board/Management Inform…
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
公告本公司董事長異動
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's chairman, detailing the resignation of the old chairman and appointment of the new chairman, including dates and reasons. It is not a financial report, earnings release, or any form of meeting material. The content fits the category of announcements about changes in the company's board or senior management.
2020-11-05 Chinese
公告本公司法人董事改派代表人
Board/Management Information Classification · 100% confidence The document is a short announcement (647 characters) about a change in the representative of a corporate director (法人董事改派代表人) for the company 中化生. It specifies the old and new representatives, the effective date, and the reason for the change. There is no financial data, no report attached or referenced, and it is clearly about a board/management change. According to the definitions, this fits the category 'Board/Management Information (MANG)'. The document is not a report or a regulatory filing fallback, but a direct announcement of management change.
2020-11-05 Chinese
本公司負責人於最高法院109年台上字第3424號案件判決。
Legal Proceedings Report Classification · 100% confidence The document is a legal proceedings update involving the company's chairman and a Supreme Court ruling. It details the case number, court decisions, and the impact on the company, explicitly mentioning legal events and court actions. There is no financial data, no report attached or referenced as being published, and no indication of other report types. This fits the definition of a Legal Proceedings Report (LTR). The document length is short and focused on legal matters, not a report publication or certification.
2020-11-04 Chinese
109年09月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, chairman, general manager, and other executives, with specific numbers of shares held, increases, decreases, and related notes. The content focuses on personal share transactions and holdings by company insiders. There is no indication of financial statements, earnings data, or report announcements. The document is not a general regulatory filing or a report publication announcement but a detailed insider shareholding disclosure. Therefore, it fits the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length and detail support this classification with high confidence.
2020-10-12 Chinese
109年09月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current holdings, pledged shares, and related information. It is focused on insider shareholdings and does not contain financial statements, earnings data, or management discussion. The document length is 2906 characters, which is relatively short and it does not mention any report publication or certification. The content matches the description of a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives. Therefore, the appropriate classification is Director's Dealing (DIRS).
2020-10-12 Chinese
109年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 中化生, reporting on the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains no detailed financial statements, management discussion, or audit information. The content is concise and factual, typical of a regulatory compliance announcement rather than a full report. Given the short length (602 characters) and the nature of the data, this fits best as a Regulatory Filing (RNS), which covers miscellaneous compliance and regulatory disclosures that do not fit other categories.
2020-10-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.